PRF Technologies Ltd.

US$0.87As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PRFXHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (76.16%)
Div yield —
ROE (45.33%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.14
PE TTM —
TSR TTM (85.95%)
Mkt cap US$3.047M
ROIC (26.44%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.895
2.78%
265.23%
Hold 4|11|8|4|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
19.26%
8.00%
14.24%
14.17%
Revenue$M
0.294
0.304
0.299
0.300
6.04%
7.91%
4.33%
1.69%
Peers (US$3.047M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.390
(0.342)
(0.303)
EBIT/Intx
1.038
0.861
0.758
Own earn%
(332.89)
114.94
110.88
Sh yield%
18.53
12.99
15.31
Owners
Insiders/Inst%
2.87
31.33
Short interest%
3.73
SBC / revenue%
5.14
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
5–10
$1 testx
0.0
Incr. ROIC%
6